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We conducted a retrospective survey in pediatric centers belonging to the Italian Society for Pediatric Diabetology and
Endocrinology. The following data were collected for all new-onset diabetes patients aged 0–18 years: DKA (pH < 7.30), severe
DKA (pH < 7.1), DKA in preschool children, DKA treatment according to ISPAD protocol, type of rehydrating solution used,
bicarbonates use, and amount of insulin infused. Records (𝑛 = 2453) of children with newly diagnosed diabetes were collected
from 68/77 centers (87%), 39 of which are tertiary referral centers, the majority of whom (𝑛 = 1536, 89.4%) were diagnosed in the
tertiary referral centers. DKAwas observed in 38.5% and severe DKA in 10.3%. Considering preschool children, DKAwas observed
in 72%, and severe DKA in 16.7%. Cerebral edema following DKA treatment was observed in 5 (0.5%). DKA treatment according to
ISPAD guidelines was adopted in 68% of the centers. In the first 2 hours, rehydration was started with normal saline in all centers,
but with different amount. Bicarbonate was quite never been used. Insulin was infused starting from third hour at the rate of 0.05–
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0.1 U/kg/h in 72% of centers. Despite prevention campaign, DKA is still observed in Italian children at onset, with significant
variability in DKA treatment, underlying the need to share guidelines among centers.
1. Introduction
Diabetic ketoacidosis (DKA) is a metabolic derangement
characterized by the triad of hyperglycemia, acidosis, and
ketosis that occurs in the presence of very low levels of
effective insulin action. DKA is a current threat for children
with type 1 diabetes and its epidemiology is variable in
various countries [1, 2]. The frequency of DKA at diagnosis
ranges from 12.8% to 80% and is lowest in Sweden, the
Slovak Republic, and Canada and highest in the United Arab
Emirates, Saudi Arabia, and Romania [1]. The frequency of
DKA is lower in countries where the background incidence
of type 1 diabetes is higher and in countries further from the
equator and with a lower gross domestic product [1].
All DKA episodes are theoretically preventable when
care of children with type 1 is appropriate [3] and specific
prevention campaigns are carried out [4]. However, to date,
DKA is still a problem for patients with type 1 diabetes.
For this reason, several national and international guide-
lines on DKA treatment and management have been pub-
lished [5–8], even if a real agreement (grade A evidence) is
still lacking, except on a few key points.
Incidence and rate of complications of DKA and its treat-
ment are largely dependent on various parameters including
type 1 diabetes incidence in a certain area, age of the child,
and access to care of patients and their families [9].
Epidemiology of DKA at diabetes diagnosis in Italy dates
back to quite 10 years ago [10] and included only few areas
with data coming from regional centers [11].
In Italy health care is provided free of charge by family
pediatricians throughout the country and once diagnosed
quite all children are managed by pediatricians belonging to
the Italian Society for Pediatric Endocrinology and Diabetol-
ogy (ISPED), many of whomwork in tertiary referral centers.
The aim of the present study is to evaluate DKA incidence
at diagnosis in Italy during the calendar years 2012-2013
in subjects 0–18 years old and to evaluate similarities or
differences in DKA management among centers.
2. Methods
A survey to collect recent data and investigate DKA epidemi-
ology and management has been given to all pediatricians
belonging to theDiabetes StudyGroup of the ISPED (𝑛 = 77).
Each center referring to the ISPED has been asked to
review all records of patients under 19 years of age, who had
diabetes onset between January 1, 2012, and December 31,
2013.
For each patient several pieces of information have been
requested as well as for the center itself: in detail for the
patients, date of birth, date at diabetes onset, pH value at
diabetes onset (to evaluate DKA severity), which kind of
DKA treatment has been used (if any protocol has been
followed, e.g., ISPAD protocol for DKA or others), measure-
ment of beta-hydroxybutyrate in the blood (yes or no), and
any treatment complication (e.g., cerebral edema), for the
center, which kind of center (first, second, or third referral
center) and if a pediatric diabetologist is always present at
new patient admission. First and secondary referral centers
have been considered all centers in which patients usually
receive primary and secondary care from professionals such
as a primary care physician (general practitioner or family
physician), or medical specialists (pediatric diabetologists),
who take care of less than 100 patients with type 1 diabetes.
Tertiary referral centers are hospitals or university hospitals
that provide tertiary care formore than 100 patients with type
1 diabetes in pediatric age.
In the final analysis the following data have been taken
into consideration: number of patients 0–18 years of age
with diabetes onset in the observation period, number of
patients under 6 years of age, number of patients with DKA
(either as total number or as patients under 6 years of age),
number of patients with severe DKA (either as total number
or as patients under 6 years of age), number of patients
who presented cerebral edema, number of centers following
any DKA protocol and which one, DKAmanagement details
(kind of fluid administered in the first and second hour, at
which infusion rate, type of fluid used starting from the third
hour, when insulin has been started and at which dosage, and
usage of bicarbonate and in which circumstances), centers
details like first/second referral centers or third referral
centers, local epidemiology registry (yes or no), and presence
of pediatric emergency department (yes or no).
DKA has been defined according to ISPAD biochemical
criteria [6] (e.g., blood glucose > 11mmol/L [≈200mg/dL];
venous pH < 7.3 or bicarbonate < 15mmol/L; ketonemia and
ketonuria). The severity of DKA has been categorized by the
degree of acidosis: (1) mild: venous pH < 7.3 or bicarbonate <
15mmol/L; (2) moderate: pH < 7.2, bicarbonate < 10mmol/L;
(3) severe: pH < 7.1, bicarbonate < 5mmol/L [6].
Data has been analyzed together for the calendar years
2012 and 2013. To evaluate possible statistical differences
between groups, chi-square test has been used and a statistical
significance has been determined at 𝑝 < 0.05.
3. Results
Among the 77 centers belonging to the ISPED, 68 (87%) of
them answered to our survey and returned complete data
records of their newly diagnosed diabetes patients. Thirty-
four centers are located inNorthern Italy, 11 centers inCentral
Italy, and 23 centers in Southern Italy.
Among the 68 responders centers there are 100% of the
tertiary referral centers of the ISPED so that the coverage
of new diabetes cases in children 0–18 years of age has been
pretty complete for the observational period (calendar years
2012 and 2013).
The 68 centers had a whole number of 14.493 children,
adolescents, and young adults (under age 18) with type 1
diabetes. The tertiary referral centers were thirty-nine (each
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Table 1: Demographic characteristic of the 68 participating centers, according to being primary/secondary or tertiary referral centers.
All (𝑛 = 68) Primary/secondaryreferral centers (𝑛 = 29)
Tertiary referral
centers (𝑛 = 39) 𝑝
Local registries (𝑛/%) 43 (63.2) 17 (58.6) 26 (66.6%) <0.001
Pediatric emergency unit (𝑛/%) 28 (41) 0 (0) 28 (71.8) <0.0001
DKA treatment led by pediatric
diabetologist (𝑛/%) 10 (14) 0 (0) 10 (25.6) <0.0001
DKA treatment led by general
pediatrician with pediatric
diabetologist on the phone (𝑛/%)
45 (66) 16 (56.2) 29 (74.4) <0.05
DKA treatment led by general
pediatrician (𝑛/%) 13 (19) 13 (19) 0 (0) <0.0001
Table 2: Diabetic ketoacidosis incidence in the whole pediatric population (0–18 years) in the calendar years 2012 and 2013 in Italy.
All (𝑛 = 68) Primary/secondaryreferral centers (𝑛 = 29)
Tertiary referral
centers (𝑛 = 39) 𝑝
Total T1D patients (𝑛/%) 14493 (100) 1533 (10.5) 12960 (89.5) <0.0001
Patients with T1D onset (𝑛/%) 2453 (100) 320 (13) 2133 (87) <0.0001
Patients with DKA at T1D onset (𝑛/%) 945 (38.5) 114 (35.6) 831 (39.0) 0.562
Patients with severe DKA at T1D onset
(𝑛/%) 253 (10.3) 35 (10.6) 218 (10.2) 0.893
Preschool patients with T1D onset (𝑛/%) 618 (100) 542 (87.7) 76 (12.3) <0.0001
Preschool patients with DKA at T1D
onset (𝑛/%) 445 (72)
∗ 414 (76.4)∗ 31 (40.8) <0.001
Patients with severe DKA at T1D onset
(𝑛/%) 103 (16.6)
∗∗ 94 (22.7)∗∗ 13 (17.1)∗∗ <0.05
DKA = diabetic ketoacidosis; T1D = type 1 diabetes.
∗
𝑝 < 0.001 preschooler versus all; ∗∗𝑝 < 0.05 preschooler versus all.
of whom take care for at least 100 patients or more), while
primary/secondary referral centers were 29. Most of the
14.493 patients are followed up at the tertiary referral centers:
12.960/14.493 (89.4%).
The demographic characteristics of the participating cen-
ters are shown in Table 1. Most of them, especially tertiary
referral ones (𝑝 < 0.001), have local registries, and only a
minority (all tertiary referral ones) show a pediatric emer-
gency unit. Looking at the person in charge for theDKA treat-
ment, only a few (all tertiary referral centers) have dedicated
personnel (pediatric diabetologist), while most leave DKA
management to the general pediatrician, sometimes with the
telephone help from a pediatric diabetologist.
In the years of the survey (2012/2013), a total of 2453
children 0–18 years of age have been diagnosed with type
1 diabetes in the 68 responder centers, and their records
have been evaluated and reviewed for the present study.
Unfortunately because of the retrospective nature of the
survey, most of the data have been presented by each center
in pooled format so that possible interesting analysis, like the
distribution of age and gender of patients with DKA at onset,
or the monthly incidence and local differences, has not been
presented.
DKA has been observed in 945/2453 patients (38.5%),
with severe DKA in 10.3% (Table 2). Evaluating DKA
occurrence and tertiary versus primary/secondary referral
centers, no difference has been observed either for total DKA
(𝑝 = 0.562) or severe DKA (𝑝 = 0.893) (Table 2).
Evaluating DKA occurrence in preschool children (6
years of age or younger), total DKA has been observed in
445/618 patients (72%) (𝑝 < 0.001 versus patients >6 years
of age) and severe DKA in 103/618 patients (16.6%) (𝑝 < 0.05
versus patients >6 years of age) (Table 2). These significant
differences between all patients and preschoolers have been
confirmed also when patients have been evaluated according
to referral centers (Table 2).
Cerebral edema as a consequence of DKA management
has been observed only in 5/945 patients (0.53%), all occur-
ring in third referral centers.
All 68 responder centers declared to manage DKA
according to written protocols: 46 centers (68%) use IDF/
ISPAD guidelines [6], 15 centers used a protocol based on
Lestradet indications [12], or slightlymodifiedwith respect to
the one utilized during the IMDIAB study, called GETREM
[13], and 7 centres (10%) used local protocols not referring to
any international recommendation.
Regarding DKA management, all 68 responder centers
declared to use 0.9% saline during the first 2 hours, but at
different infusion rates: 48 centers (71%) infused saline at 5–
10mL/kg/h, 11 (16%) at 10–20mL/kg/h, and 3 (4%) at less than
5mL/kg/h, and 6 (8%) calculated infusion rate according to
square meter (usually 3 L/m2 [12]).
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After the first 2 hours, all 68 centers agree that the amount
of fluids to be infused never have to exceed 3 L/m2/day, even
if there was no agreement on the calculation (considering or
not the amount of fluids infused during the first 2 hours).
Moreover, a great difference has been observed regarding the
nature of fluid infused after the first 2 hours: saline either
0.9% or 0.45% in 51 centers (75%), 5%–10% glucose solution,
irrespective of glycemic values, in 13 (19%), and different
solutions in the remaining 4.
Hypotonic solutions were never used when blood glu-
cose was >14–18mmol/L (>250–300mg/dL); however, when
blood glucose fell below that value, nonhypotonic solutions
(containing at least 77mEq/L of sodium)were used in 30 cen-
ters (44.1%), whereas glucose 5–10% solutions with sodium
concentration ranging from 0 to 34mEq/L (hypotonic) were
used in 38 (65.9%).
Potassiumwas supplemented in all 68 centers, but supple-
mentation was performed at different rates: 20–40mEq/L in
43 (63%), calculated as mEq/kg/h in the remaining 25 (37%).
Sodium was not supplemented in any of the participating
centers. However, because of its importance for determining
osmolality it was determined in all patients in all centers.
Bicarbonates were never used in 22 centers (32%), while
they were exceptionally used according to pH and clinical
conditions in 46 (68%).
Regular insulin was infused using an automated syringe
in 53 centers (78%), while it was injected directly in the
fluid solution in 15 (22%). Insulin was infused starting from
second or third hour in all 68 centers, mostly according
to DKA severity. Insulin infusion rate was 0.05–0.1 U/kg/h
in 49 centers (72%), while the rest used lower rates (0.02–
0.07U/kg/h).
Serum beta-hydroxybutyrate to rate DKA severity and to
evaluate DKAmanagement follow-upwasmeasured in 43/68
centers (63%).
4. Discussion
The present survey provides a comprehensive depiction of
DKA epidemiology and management in 68/77 centers that
reviewed records of all newly diagnosed children 0–18 years
old with type 1 diabetes in Italy during the calendar years
2012/2013.
Although the present data do not come from official
diabetes registries and do not cover all the Italian country
(11 centers did not send their data), we believe to give an
enough satisfactory situation of DKA at diabetes onset in
children younger than 19 years in Italy. This is because of
the high number of patients represented by centers involved
(𝑛 = 14.493 patients) and because all tertiary referral centers
in Italy participated in the survey, accounting for quite 90%
of patients involved in the study. Likewise, the centers that
did not contribute to the survey are primary referral centers
with a few patients each. Finally, the Italian Statistic Institute
(ISTAT) esteems that the number of patients younger than 18
years of age in Italy is around 15.000–20.000.
Few years ago, Henriksen et al. [14] published a similar
survey, led in adult patients with type 1 diabetes in Denmark.
They achieved comparable country coverage (88% versus our
87%) and observed wide DKA treatment differences among
centers, as we did, giving still higher reliability to our results.
Indeed, an interesting finding of the present survey is that,
despite international recommendations, most of the Italian
centers managing DKA in children with type 1 diabetes onset
do not have a pediatric intensive care unit in their hospital,
do not measure serum beta-hydroxybutyrate, and do not
infuse insulin with an automated syringe. On the other hand,
children with type 1 diabetes onset are managed by pediatric
diabetologists in most of the cases, directly in 14%, or via
phone consultation in 66%. Even with the lack of national
regulation to claim the need for regional centers to manage
all children with type 1 diabetes, this might be considered
the result of the effective policy of our Society in actively
promoting knowledge and expertise about type 1 diabetes
management.
Another interesting finding of the present survey is the
still too high number of children who had DKA at type
1 diabetes onset, with incidence (38.5%) similar to that
reported in previous surveys led in Italy [10, 11, 15, 16], on
smaller sample size and dating back to like 10–20 years ago.
One possible reason might be that the Italian Health System
(Sistema Sanitario Nazionale, SSN) is organized with family
pediatricians who take care of children 0–14 years of age
free of charge. Not everyone may be aware of the occurrence
of type 1 diabetes, especially if they do not have patients
suffering from this disease. Prevention campaign [4] succeeds
in lowering DKA occurrence somewhere (Emilia Romagna
region) but not everywhere, and we need an extra effort to
gain similar results all over Italy; otherwise diabetes diagnosis
can be delayed or missed at all. In this respect, family
pediatricians can play a pivotal role in conducting effective
DKA prevention campaigns able to reduce the incidence of
DKA at type 1 diabetes onset, now unchanged for over twenty
years.
Actually, the DKA incidence observed in the present sur-
vey is higher than that observed in many Northern European
countries [1], and, recently, in the US SEARCH study [9],
ranging around 30%. It should be remembered that both
Northern European countries and the US show a higher type
1 diabetes incidence rate than Italy. In Italy the incidence rate
is 12.26/100.000/year at the age 0–14 years, except in Sardinia
that shows an incidence rate about 40/100.000/year [17].
DKA incidence is lower in higher type 1 diabetes incidence
countries [1], and this could explain the still high Italian DKA
incidence (38.5% versus 30%). Indeed, inferring Sardinian
data from general ones we found a DKA incidence of 29%,
very similar to that observed in the SEARCH study [9].
Italian DKA incidence is similar to that reported in a
recent Austrian population-based study [18]. The authors
describe a DKA incidence of 37.2% for all diabetes onsets
in the period 1989–2011. It is noteworthy that the incidence
reported is not different, as in our national data, before and
after a prevention campaign similar to the Parma campaign
[4]. In the study by Vanelli et al. DKA incidence decreased
from 78% to only 12%, highlighting the fact that similar
prevention campaign might work better when applied in a
small area (Emilia Romagna region) instead of a national area
(e.g., Italy and Austria).
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No difference regarding DKA incidence as a whole
has been observed between tertiary referral and pri-
mary/secondary referral centers. However, considering DKA
in preschoolers [9, 18, 19], third referral centers showed a
significantly higher incidence than primary/secondary refer-
ral ones. The explanation for this is probably the fact that
in some area DKA episodes at diabetes onset (especially the
more severe ones) in the preschoolers are referred from little
hospitals to tertiary referral centers, without the possibility
for the latter to lead a real prevention campaign or an early
diagnosis of type 1 diabetes. This underlines the need of
education and prevention programs, specifically addressed to
this particularly vulnerable age group.
A great difference among centers has been observed also
regarding the DKA management guidelines used. All agree
to use 0.9% saline during the first 90–120min; however, no
agreement exists regarding the infusion rate, that differed
largely according to the different protocols used. Similarly, a
great difference exists regarding the type of fluids used after
the first 2 hours.
While a general agreement occurs about the total amount
of fluids to infuse (e.g., not to exceed 3 L/m2/day), differences
have been observed in the methods to calculate it. This
is probably due to the increasing evidence [20] that too
many fluids are a risk factor for cerebral edema and possibly
due to the fact that all pediatricians are more familiar
with management of dehydration from various causes in
children. The survey from Denmark in adult patients with
type 1 diabetes [14] reported in the first 8 hours extensive
differences in infused volumes, ranging from 3750mL/day to
7700mL/day, greater than the ones observed in the present
survey.
There were no important disagreements in potassium
and sodium infusion, possibly because there is a general
agreement on their use in the existing guidelines.
Even though 68% of responder centers referred to the
IDF/ISPAD guidelines [6], other protocols are still used,
especially the “old” Lestradet protocol [12] consisting of
an infusion of 10% glucose isotonic solution after 2-hour
rehydration period. This may be explained by the historical
importance of Lestradet protocol both in the ISPAD and in
ISPED teaching schools and the fact that DKA treatment
evidences are not of grade A level, highlighting the need
for specifically designed randomized controlled trial, as the
ongoing therapeutic trial recently published [21]. However,
it is remarkable that when blood glucose starts dropping
below 14–18mmol/L (250–300mg/dL), 56% of centers seem
to not pay attention to using hypotonic solutions, as recently
suggested byWhite andDickson [22] who primarily focus on
glucose concentration.
If all centers infuse human regular insulin, no agree-
ment ensues regarding insulin infusion rate: most of cen-
ters infuse insulin at a rate of 0.05–0.1 U/kg/h, while 28%
infuse insulin at a lower rate. Low dose is not inferior
to standard dose with respect to rate of blood glucose
decrease and resolution of acidosis, as showed previously
[23] and in very recent randomized and controlled trial
[24].
Cerebral edema, the most life-threatening complication
of DKA, was reported in only few cases, with frequency
(0.5%) similar to that described in a much larger case series
by White and Dickson [22]. These data possibly suggest that,
despite the nonhomogeneous attitude of Italian pediatric dia-
betologists to follow international guidelines, the protocols
used rarely included bicarbonate infusion and the use of
hypotonic solutions, factors associated with an increased risk
of cerebral edema.
However, as well reviewed byWolfsdorf in one of the last
issues of Pediatric Diabetes, controversy persists concerning
the appropriate starting dose of insulin for the treatment of
DKA and the optimal fluid treatment regimen for pediatric
DKA, also at an international level [25].
The present survey shows some limitations, the most
significant being its retrospective design.Moreover, the estab-
lishment of a central registry will be of outmost importance
for the validity and double check on the reliability of data
collected. Additionally, total days of hospitalization, outcome
of patients, and more demographic and epidemiological data
need to be considered in future surveys on DKA in pediatric
patients with type 1 diabetes.
In conclusion, the present survey describes an updated
picture of what happens in Italy about incidence and
management of DKA in children with type 1 diabetes.
An awkwardly high DKA incidence at diagnosis has been
observed, especially in preschool children, irrespective of
specific prevention campaign carried out during the last
years. Even if consistency in fundamental key points of DKA
treatment has been perceived, some differences exist about
treatment protocols, highlighting the need for their more
effective sharing among centers [26].
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